Real-life treatment of patients with advanced pancreatic cancer in Germany – data from the clinical registry pancreatic cancer (TPK). 6. Juni 2014 Hegewisch-Becker, S., Hofheinz, R.-D., Hartmann, H., Kopfmann, S., Marschner, N., 2014. Oncol Res Treat 37(Suppl.5)(P274), 86. doi:10.1159/000368945 Abstract Download Maintenance strategy with fluoropyrimidines (FP) plus bevacizumab (Bev), Bev alone, or no treatment, following a standard combination of RP, Oxaliplatin (Ox), and Bev as first-line treatment for patients with metastatic colorectal cancer (mCRC): Results of the AIO KRK 0207 phase III study. Hegewisch-Becker, S., Arnold, D., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C.-C., Al-Bartan, S.-E., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher-Schick, A., Tannapfel, A., Quidde,… Weiterlesen Multiple myeloma and neurotoxicity: Patient-reported and physician-recorded findings from the German prospective TLN Registry and the LyTox project. Hurtz, H.-J., Knauf, W., Hutzschenreuter, U., Mittermüller, J., Grugel, R., Harde, J., Boller, E., Hartmann, H., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(P861),… Weiterlesen